Apple CEO's Silence Says More Than His PR Team

July 31, 2008 at 2:17 am PT

Phew. Apple Inc.’s iconic Chief Executive Steve Jobs does not have a recurrence of the pancreatic cancer he successfully battled four years ago.

At least that is what investors learned by reading the New York Times, in an odd culmination of events that started last week, after Apple (AAPL) reported its second-quarter earnings and an analyst gently asked about Jobs’s health on the conference call.

Chief Financial Officer Peter Oppenheimer’s reply that Jobs “has no plans to leave Apple” and that his “health is a private matter” did nothing to assuage investors’ fears that the legendary CEO could be ill again, based on his gaunt appearance at Apple’s Worldwide Developers Conference in June and renewed media speculation last week.

Read the rest of this post

Tagged with: Apple, frontpage, Joe Nocera, MarketWatch, pancreatic cancer, Peter Oppenheimer, Steve Jobs, Tech Tales, The New York Times, Therese Poletti, WWDC

Must-Reads from other Websites

Why Apple Should Buy China’s Xiaomi

Panos Mourdoukoutas, Contributor, Forbes

What I Didn’t Say

Paul Graham, Founder, ViaWeb

We Need to Talk About TED

Benjamin Bratton, Journalist, The Guardian

I, Glasshole: My Year With Google Glass

Mat Honan, Senior Writer, Wired

All Together Now

Chris Ware, Writer, The New Yorker

The Sculpture on the Moon

Corey S. Powell and Laurie Gwen Shapiro, Contributors, Slate

About Voices

Along with original content and posts from across the Dow Jones network, this section of AllThingsD includes Must-Reads From Other Websites — pieces we’ve read, discussions we’ve followed, stuff we like. Six posts from external sites are included here each weekday, but we only run the headlines. We link to the original sites for the rest. These posts are explicitly labeled, so it’s clear that the content comes from other websites, and for clarity’s sake, all outside posts run against a pink background.

We also solicit original full-length posts and accept some unsolicited submissions.